Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
Go back to Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.| (NASDAQ: SOPH) | Delayed: 5.30 -0.04 (0.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.34 | 52 Week High | $ | |||
| Open | $5.29 | 52 Week Low | $ | |||
| Day High | $5.35 | P/E | N/A | |||
| Day Low | $5.22 | EPS | $ | |||
| Volume | 18,072 | |||||

